CD274 and Miyoshi myopathy: However, monotherapy with PD-1/PD-L1 inhibitors has yielded unsatisfactory results, and even the combination of anti-PD-1 with IMiDs, such as lenalidomide or pomalidomide, showed limited clinical benefits in MM patients [48,49,50].